Home   Site Map   About Roche   Contact Us   Help   
This is a alt text for OncologyThis is a alt text for Oncology
Clinical. Credible. Convenient.
Not a Member? Log In Forgot Password? Instant Access Code
Sign Up
»
E-mail: Password: Code:
  Remember Me Log In
»
Go
»
Main Menu
Meeting Calendar

Select a link below to view details.
Previous July 2010 Next
S M T W T F S
        1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31
Oncology Clinical Trials

Oncology Clinical Trials Database
Real-time, comprehensive global Oncology clinical trials database

  • Global clinical development on a trial-by-trial basis
  • Search by any drug name
  • Search by any status and/or phase of the trial
TrialTrove™Locked Content Click
Here
 
  What is this?
 
   
 
Roche Clinical Trials
 
Recruiting A single arm, open-label trial assessing the effect of capecitabine (Xeloda® ) on progression-free survival rate at four months in breast cancer patients with CNS progression after whole brain radiotherapy
 
 
Recruiting An open label study to evaluate the safety of Xeloda as adjuvant monotherapy in patients who have undergone surgery for colon cancer, Dukes stage C.
 
 
Recruiting A randomized, open label study to assess the effect on progression-free survival and disease response of Avastin + Xeloda as maintenance treatment, after initial combination treatment with Xeloda + oxaliplatin + Avastin in patients with metastatic colorectal adenocarcinoma
 
 
Recruiting XERAD: Open-label, phase II, randomized, comparative, multicentre trial of concurrent Whole Brain Radiation Therapy (WBRT) and capecitabine (Xeloda® ) followed by maintenance capecitabine compared with standard WBRT in breast cancer patients with newly diagnosed brain metastasis
 
 
Recruiting An open label study of the effect of Xeloda and radiotherapy on pathological response rate in patients with locally advanced rectal cancer.
 
 
Recruiting A randomized, open-label study to evaluate the effect of Avastin in combination with Xeloda on progression-free survival in elderly patients with metastatic colorectal cancer
 
 
Recruiting An open label study to evaluate the effect of Avastin in association with chemotherapy on progression-free survival in patients with progressive advanced/metastatic well-differentiated digestive endocrine tumors of the gastrointestinal tract
 
 
Recruiting A prospective study to evaluate alterations in molecular biomarkers in HER2 neu positive metastatic breast cancer together with assessment of trastuzumab use beyond progression after initial response to trastuzumab-taxane based treatment
 
 
Recruiting An open label study to assess the resection rate of liver metastases following neoadjuvant therapy with Avastin in combination with oxaliplatin and capecitabine (XELOX) in patients with metastatic colorectal cancer with unresectable liver metastasis
 
 
Recruiting A single-arm open-label study on the effect on progression-free survival by adding Bevacizumab to XELOX chemotherapy as treatment beyond progression in patients with metastatic colorectal cancer and disease progression under first-line FOLFIRI + Bevacizumab combination
 
Clinical Trials Registry and Results
Visit Roche Trials for more information on completed Roche clinical studies.

ClinicalTrials.gov provides regularly updated information about federally and privately supported clinical research in human volunteers.

RocheInvestigators.com: Investigators interested in applying to participate in the U.S. arm of global development clinical trials sponsored by Hoffmann-La Roche Inc., please click the link.